BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29159778)

  • 1. Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.
    Ma R; Levy M; Gui B; Lu SE; Narra V; Goyal S; Danish S; Hanft S; Khan AJ; Malhotra J; Motwani S; Jabbour SK
    J Neurooncol; 2018 Jan; 136(2):395-401. PubMed ID: 29159778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.
    Huang AJ; Huang KE; Page BR; Ayala-Peacock DN; Lucas JT; Lesser GJ; Laxton AW; Tatter SB; Chan MD
    J Neurooncol; 2014 Oct; 120(1):163-9. PubMed ID: 25048529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
    Mix M; Elmarzouky R; O'Connor T; Plunkett R; Prasad D
    J Neurosurg; 2016 Dec; 125(Suppl 1):26-30. PubMed ID: 27903186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases.
    Vogel J; Ojerholm E; Hollander A; Briola C; Mooij R; Bieda M; Kolker J; Nagda S; Geiger G; Dorsey J; Lustig R; O'Rourke DM; Brem S; Lee J; Alonso-Basanta M
    Radiat Oncol; 2015 Oct; 10():221. PubMed ID: 26520568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.
    Rusthoven CG; Yamamoto M; Bernhardt D; Smith DE; Gao D; Serizawa T; Yomo S; Aiyama H; Higuchi Y; Shuto T; Akabane A; Sato Y; Niranjan A; Faramand AM; Lunsford LD; McInerney J; Tuanquin LC; Zacharia BE; Chiang V; Singh C; Yu JB; Braunstein S; Mathieu D; Touchette CJ; Lee CC; Yang HC; Aizer AA; Cagney DN; Chan MD; Kondziolka D; Bernstein K; Silverman JS; Grills IS; Siddiqui ZA; Yuan JC; Sheehan JP; Cordeiro D; Nosaki K; Seto T; Deibert CP; Verma V; Day S; Halasz LM; Warnick RE; Trifiletti DM; Palmer JD; Attia A; Li B; Cifarelli CP; Brown PD; Vargo JA; Combs SE; Kessel KA; Rieken S; Patel S; Guckenberger M; Andratschke N; Kavanagh BD; Robin TP
    JAMA Oncol; 2020 Jul; 6(7):1028-1037. PubMed ID: 32496550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
    Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
    Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu HG; Crocker IR; Patel KR
    Pract Radiat Oncol; 2017; 7(6):e419-e425. PubMed ID: 28668668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptomeningeal metastasis in patients with non-small cell lung cancer after stereotactic radiosurgery for brain metastasis.
    Chiang CL; Yang HC; Luo YH; Chen CJ; Wu HM; Chen YM; Hu YS; Lin CJ; Chung WY; Shiau CY; Guo WY; Chou TY; Pan DH; Lee CC
    J Neurosurg; 2023 Aug; 139(2):385-392. PubMed ID: 36681978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age.
    Watanabe S; Yamamoto M; Sato Y; Kawabe T; Higuchi Y; Kasuya H; Yamamoto T; Matsumura A; Barfod BE
    J Neurosurg; 2014 Nov; 121(5):1148-57. PubMed ID: 25061863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
    Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
    Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.
    Rades D; Kueter JD; Hornung D; Veninga T; Hanssens P; Schild SE; Dunst J
    Strahlenther Onkol; 2008 Dec; 184(12):655-62. PubMed ID: 19107346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.